ArticleMolecular cancer therapeutics2021

Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity.

Sang-In Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.